TG THERAPEUTICS
TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a novel, glycoengineered, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found o... n mature B-lymphocytes. TG Therapeutics is also developing TGR-1202, an orally available PI3K delta inhibitor. The delta isoform of PI3K is strongly expressed in cells of hematopoietic origin and is believed to be important in the proliferation and survival of B-lymphocytes. Both TG-1101 and TGR-1202 are in clinical development for patients with hematologic malignancies. TG Therapeutics is headquartered in New York City and is traded on NASDAQ under the ticker symbol "TGTX".
TG THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
1993-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.tgtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(212)554-4484
Total Funding:
205 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Employees Featured
Sean A. Power CFO @ TG Therapeutics
CFO
James White Executive Director Medical Affairs Operations @ TG Therapeutics
Executive Director Medical Affairs Operations
2020-06-01
Adam Waldman Chief Commercial Officer @ TG Therapeutics
Chief Commercial Officer
Mary Ann Johnston Senior Director & Clinical Science Liaisons @ TG Therapeutics
Senior Director & Clinical Science Liaisons
2019-11-01
Michael S. Weiss Founder, Executive Chairman, Interim President and CEO @ TG Therapeutics
Founder, Executive Chairman, Interim President and CEO
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - TG Therapeutics
Hercules Capital
Hercules Capital investment in Post-IPO Debt - TG Therapeutics
Official Site Inspections
http://www.tgtherapeutics.com Semrush global rank: 2.39 M Semrush visits lastest month: 7.67 K
- Host name: 104.26.15.118
- IP address: 104.26.15.118
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "TG Therapeutics"
Investor Relations | TG Therapeutics, Inc.
5 days ago The Investor Relations website contains information about TG Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
TG Therapeutics - Crunchbase Company Profile
TG Therapeutics, a biopharmaceutical company, develops agents for the treatment of hematologic malignancies and autoimmune disorders.See details»
TG Therapeutics, Inc. - LinkedIn
TG Therapeutics, Inc. Biotechnology Research New York, NY 35,564 followers TG is a biopharmaceutical company focused on the development of novel treatments for B-cell diseases.See details»
TG Therapeutics Company Profile | Management and Employees …
Find contact information for TG Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and TG Therapeutics's email format.See details»
TG Therapeutics Inc Company Profile - Overview - GlobalData
TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops, and commercializes pharmaceutical products for the treatment of B-cell …See details»
TG Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore TG Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 46 clinical trials, 175 news, and 11 literature, Disease Domain:Hemic and ...See details»
TG Therapeutics - Overview, News & Similar companies - ZoomInfo
Dec 16, 2024 View TG Therapeutics (www.tgtherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well …See details»
TG Therapeutics - Craft
Oct 29, 2024 TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important …See details»
TG Therapeutics (TGTX) Company Profile & Description
Dec 14, 1995 Company profile for TG Therapeutics, Inc. (TGTX) stock, with a description, list of executives, contact details and other key facts.See details»
ABOUT US - TG Therapeutics
We’ve dedicated ourselves to this simple concept and to the study of B-cells and B-cell diseases. To achieve our goal, we search the globe looking for medicines in early research that we believe could become valuable treatment options for …See details»
TG Therapeutics, Inc. - Company Profile & Staff Directory
TG Therapeutics, Inc. is a Biotechnology company located in New York, NY 10014, US with 324 employees. Access TG Therapeutics, Inc.'s email format and TG Therapeutics, Inc. staff …See details»
Working At TG Therapeutics: Company Overview and Culture
Find out what it's like to work at TG Therapeutics. See what kind of people work at TG Therapeutics, career paths working at TG Therapeutics, company culture, salaries, employee …See details»
TG Therapeutics, Inc. (LON: 0VGI) Company Profile & Overview
Jan 17, 2025 Company profile for TG Therapeutics, Inc. (LON: 0VGI) with a description, list of executives, contact details and other key facts.See details»
TG Therapeutics Reports First Quarter 2025 Financial Results and …
5 days ago The Investor Relations website contains information about TG Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
OVERVIEW - TG Therapeutics
TG Therapeutics is committed to the development of innovative medicines and unique combinations that deliver novel treatments for patients suffering from B-cell malignancies and …See details»
TG Therapeutics Ranked Number One Fastest-Growing Company …
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number one on the Deloitte Technology Fast 500 ™, a ranking of …See details»
TG Therapeutics to Participate in the Goldman Sachs 45th Annual …
Jun 7, 2024 Fireside chat scheduled for Tuesday, June 11, 2024, at 1:20 PM ET NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today …See details»
Publications - TG Therapeutics
Feb 27, 2025 We welcome you to explore our comprehensive publications database. All publications are available to download. Please select one or more fields from the list below to …See details»
What is TG Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at TG Therapeutics. Salaries, reviews, and more - all posted by employees working at TG Therapeutics.See details»
TG Therapeutics to Host Conference Call on First Quarter
Apr 30, 2025 TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update Conference call to be held Monday, May 5, 2025, at 8:30 AM ET April …See details»